iBio, Inc.IBIONYSE
Loading
Year-over-year free cash flow growth rate
Percentile
P59
Within normal range
vs 3Y Ago
0x
Contraction
Streak
2 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | -1.05% |
| Q3 2025 | -23.42% |
| Q2 2025 | -48.00% |
| Q1 2025 | 19.41% |
| Q4 2024 | -4.17% |
| Q3 2024 | 26.64% |
| Q2 2024 | -38.59% |
| Q1 2024 | 22.35% |
| Q4 2023 | 11.87% |
| Q3 2023 | 2.48% |
| Q2 2023 | -49.17% |
| Q1 2023 | 65.33% |
| Q4 2022 | 35.58% |
| Q3 2022 | -7.75% |
| Q2 2022 | -90.19% |
| Q1 2022 | 37.43% |
| Q4 2021 | 3.88% |
| Q3 2021 | -36.36% |
| Q2 2021 | -16.91% |
| Q1 2021 | 11.12% |
| Q4 2020 | -23.00% |
| Q3 2020 | -63.74% |
| Q2 2020 | -20.40% |
| Q1 2020 | -7.45% |
| Q4 2019 | -55.93% |
| Q3 2019 | 49.24% |
| Q2 2019 | -6.81% |
| Q1 2019 | 15.52% |
| Q4 2018 | -374.13% |
| Q3 2018 | 70.82% |
| Q2 2018 | 8.23% |
| Q1 2018 | -5.17% |
| Q4 2017 | -21.13% |
| Q3 2017 | 27.09% |
| Q2 2017 | -11.02% |
| Q1 2017 | -3.68% |
| Q4 2016 | -29.63% |
| Q3 2016 | 0.24% |
| Q2 2016 | -18.16% |
| Q1 2016 | -45.87% |